TIL When the leading emergency asthma medication Albuterol’s patent expired, the patent holding pharmaceutical companies lobbied to have their own inhalers banned based on environmental issues, allowing them to file a new patent, and continue to monopolize the market.

http://www.motherjones.com/kevin-drum/2013/10/heres-why-your-asthma-inhaler-costs-so-damn-much